Gilead Sciences' (GILD) Outperform Rating Reiterated at Robert W. Baird

Gilead Sciences' (GILD) Outperform Rating Reiterated at Robert W. Baird

The stock had a trading volume of 10,125,177 shares. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since September 11, 2016 and is downtrending. It has underperformed by 16.70% the S&P500. The stock had a trading volume of 4,978,225 shares. The stock now has Weekly Volatility of 2.21% and Monthly Volatility of 1.94%.

Since March 30, 2017, it had 0 insider purchases, and 7 insider sales for $16.39 million activity. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) for 12,180 shares. (NASDAQ:GILD) was sold by Cogan John Francis.

EVP Comm&Acs ALA, Corp&Med Aff Gregg H. Alton sold 40,000 shares at an average price of $74.00 on Friday the 21st.

This represents an increase of 6% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks. Its down 0.69, from 1.82 in 2016Q3. (GILD)'s shares. The total value of these holdings, in millions, is $83,999. 111 funds opened positions while 421 raised stakes. State Street Corporation invested in 0.41% or 60.45 million shares. Wells Fargo And Mn accumulated 0.29% or 11.31M shares. Northwestern Mutual Wealth Mgmt holds 0% or 250 shares in its portfolio. BMO Capital Markets restated an "outperform" rating and set a $82.00 target price (up from $72.00) on shares of Gilead Sciences in a report on Thursday, July 27th. (NASDAQ:GILD) for 110,986 shares. The Pennsylvania-based Vanguard Group has invested 0.34% in Gilead Sciences, Inc. (NASDAQ:GILD). Sandy Spring Bank & Trust owns 45,523 shares or 0.34% of their USA portfolio. Perkins Investment Mngmt Limited Company holds 0% in Gilead Sciences, Inc. Bradley Foster And Sargent Incorporated Ct holds 104,092 shares. Palisade Mgmt Ltd Nj has 0.03% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 13,000 shares. Alpine Woods Cap Limited Liability Company has invested 0.13% in Gilead Sciences, Inc. (NASDAQ:GILD) for 88,248 shares.

The company has mean EPS estimate of 1.93 reported by 20 number of analyst for the quarter ending Current Qtr.(Sep2017). CMP's SI was 7.18M shares in September as released by FINRA. It also upped Ca Inc (NASDAQ:CA) stake by 75,330 shares and now owns 134,665 shares.

Covering sell-side analysts have recently weighed in on shares of Medtronic plc (NYSE:MDT). Therefore 63% are positive. Deutsche Bank AG restated a "buy" rating and issued a $81.00 price objective (up from $79.00) on shares of Gilead Sciences in a research report on Thursday, July 27th. The rating was maintained by Needham on Wednesday, July 29 with "Buy".

For the Current Quarter, the growth estimate for Gilead Sciences -23.3%, while for the Next Quarter the stock growth estimate is -28.5%. Finally, Berenberg Bank reaffirmed a "buy" rating and issued a $96.00 target price (up previously from $86.00) on shares of Gilead Sciences in a research note on Wednesday, September 6th. As per Friday, April 29, the company rating was maintained by Citigroup. RBC Capital Markets has "Outperform" rating and $120 target. The company was maintained on Tuesday, May 30 by Cowen & Co.

Medtronic plc (NYSE:MDT) and Gilead Sciences, Inc. (NASDAQ:GILD) Volume Spiking Mid-session

Analysts await Donaldson Company, Inc. The Firm is engaged in the discovery and development of small molecule drugs.

Investors sentiment decreased to 1.13 in 2016 Q4. Its up 0.08, from 1.05 in 2016Q3. 8 funds opened positions while 9 raised stakes. Burney stated it has 47,313 shares or 0.23% of all its holdings. Stonebridge Advsrs Ltd Llc invested in 0.45% or 21,352 shares. Nationwide Fund has 17,367 shares. Partnervest Advisory Ser invested in 0.12% or 3,607 shares. 69,847 are held by Blackrock Advsrs Lc. Markel Corp stated it has 0.02% of its portfolio in Gilead Sciences, Inc. Cormorant Asset Mngmt Ltd Liability Corp holds 538,422 shares. Eaton Vance Mngmt has invested 0.01% in PerkinElmer, Inc. Federated Investors Pa invested 0% of its portfolio in PerkinElmer, Inc.

Gilead Sciences Inc. shares increased 1.66 percent over the past week and rose 15.16 percent over the previous month. Delta Lloyd Nv invested in 0.57% or 252,584 shares.

Zwj Investment Counsel Inc increased General Electric (NYSE:GE) stake by 13,512 shares to 127,912 valued at $4.04M in 2016Q4. Therefore 88% are positive. Stock Spirits Group had 53 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Aegis Capital on Thursday, June 29 with "Buy".

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Jefferies has "Buy" rating and $95 target. As per Tuesday, March 15, the company rating was maintained by Jefferies. As per Monday, November 9, the company rating was downgraded by UBS. The stock of Roka Bioscience Inc (NASDAQ:ROKA) has "Market Perform" rating given on Monday, March 7 by Leerink Swann.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

More news: Fidelity National Financial, Inc. (NYSE:FNF) Upgraded to "Buy" by ValuEngine

Related Articles